Melatonin and certain sedative-hypnotic medications can modulate sleep-wake cycles and potentially reduce the frequency and intensity of cluster headache attacks by interacting with circadian rhythm regulators and neurological pain pathways. These agents primarily work by binding to melatonin receptors or GABA receptors, promoting neuronal inhibition and facilitating sleep onset, which may help interrupt the neurological triggers associated with cluster headache episodes.